Smoking Increases Risk for Adverse Cardiovascular Outcomes After PCI
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Sept. 27, 2023 -- For patients undergoing percutaneous coronary intervention (PCI), smoking is associated with an increased risk for adverse cardiovascular outcomes, according to a study published online Sept. 27 in the European Heart Journal.
Using a nationwide database from the Korean National Health Insurance System, You-Jeong Ki, M.D., from the Uijeongbu Eulji Medical Center in the South Korea, and colleagues examined the impact of smoking and its cessation after PCI on cardiovascular outcomes among 74,471 patients undergoing PCI between 2009 and 2016. Participants were classified as nonsmokers, ex-smokers, or current smokers, depending on their status at the first health checkup within one year following PCI.
The researchers found that current smokers had a 19.8 percent higher rate of major adverse cardiovascular and cerebrovascular events (MACCE) than nonsmokers during 4.0 years of follow-up (adjusted hazard ratio, 1.198), while the rate was comparable for ex-smokers and nonsmokers. The effects of smoking cessation were analyzed among 31,887 patients with both pre- and post-PCI health check-up data. For those who stopped smoking after PCI, the rate of MACCE was comparable for quitters with cumulative smoking exposure of <20 pack-years (PYs) and persistent nonsmokers. However, quitters with cumulative exposure of ≥20 PYs had a rate that was comparable with that of persistent smokers (adjusted hazard ratios, 1.206 for 20 to 30 PYs; 1.227 for ≥30 PYs; and 1.223 for persistent smokers compared with persistent nonsmokers).
"Smoking cessation as early as possible would be recommended as a fundamental measure of better clinical outcomes for patients undergoing PCI," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted September 2023
Read this next
AI-Informed Health App Aids Diabetes Outcomes
WEDNSDAY, May 15, 2024 -- Use of an artificial intelligence (AI)-informed health app aids diabetes outcomes and cuts atherosclerotic cardiovascular disease (ASCVD) risk, according...
Fat-Enlarged Axillary Nodes on Mammogram May Indicate Higher CVD Risk
TUESDAY, May 14, 2024 -- Fat-enlarged axillary nodes on screening mammograms can predict the risk for cardiovascular disease (CVD), according to a study presented at the annual...
Adding Cardiovascular Biomarkers to Established Risk Factors Increases Risk Prediction
MONDAY, May 13, 2024 -- The addition of cardiovascular biomarkers to established risk factors leads to a small improvement in risk prediction of cardiovascular disease, according...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.